Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Jennison Associates LLC

Jennison Associates LLC lessened its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 410,937 shares of the company's stock after selling 15,378 shares during the period. Jennison Associates LLC owned 0.83% of Prestige Consumer Healthcare worth $29,629,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of PBH. Lombard Odier Asset Management USA Corp purchased a new position in Prestige Consumer Healthcare in the 2nd quarter valued at about $550,000. CANADA LIFE ASSURANCE Co lifted its stake in shares of Prestige Consumer Healthcare by 19.4% during the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company's stock valued at $3,453,000 after buying an additional 7,715 shares during the period. Sequoia Financial Advisors LLC boosted its position in Prestige Consumer Healthcare by 12.9% during the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company's stock worth $708,000 after acquiring an additional 1,120 shares during the last quarter. Atria Investments Inc purchased a new stake in Prestige Consumer Healthcare in the 1st quarter worth approximately $1,246,000. Finally, Public Employees Retirement System of Ohio raised its holdings in Prestige Consumer Healthcare by 20.5% in the 1st quarter. Public Employees Retirement System of Ohio now owns 80,950 shares of the company's stock valued at $5,874,000 after acquiring an additional 13,760 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. DA Davidson restated a "buy" rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $83.67.

Insider Buying and Selling

In related news, CEO Ronald M. Lombardi sold 10,875 shares of the company's stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the completion of the sale, the chief executive officer now directly owns 320,952 shares of the company's stock, valued at approximately $26,510,635.20. This represents a 3.28 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Adel Mekhail sold 9,063 shares of the firm's stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total value of $743,166.00. Following the completion of the transaction, the executive vice president now directly owns 18,365 shares in the company, valued at $1,505,930. This trade represents a 33.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,810 shares of company stock valued at $3,187,300. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Trading Up 0.8 %

Shares of NYSE PBH traded up $0.66 during trading on Friday, hitting $84.80. 140,396 shares of the company traded hands, compared to its average volume of 251,126. The firm has a market capitalization of $4.19 billion, a P/E ratio of 20.46, a P/E/G ratio of 2.32 and a beta of 0.47. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The company has a 50-day moving average price of $74.13 and a 200-day moving average price of $70.57. Prestige Consumer Healthcare Inc. has a 1 year low of $56.61 and a 1 year high of $85.22.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm's quarterly revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.07 earnings per share. On average, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.